BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,062,947 | -29.6% | 28,165 | -15.0% | 0.02% | -25.8% |
| Q2 2023 | $1,509,722 | +3.0% | 33,137 | -8.3% | 0.03% | +3.3% |
| Q1 2023 | $1,465,311 | -23.5% | 36,127 | -3.9% | 0.03% | -23.1% |
| Q4 2022 | $1,915,249 | +11.4% | 37,576 | +17.8% | 0.04% | +8.3% |
| Q3 2022 | $1,719,000 | -11.1% | 31,909 | +6.0% | 0.04% | -2.7% |
| Q2 2022 | $1,934,000 | -7.9% | 30,105 | +11.1% | 0.04% | +15.6% |
| Q1 2022 | $2,101,000 | -15.0% | 27,092 | -5.9% | 0.03% | -8.6% |
| Q4 2021 | $2,471,000 | +25.4% | 28,791 | +17.5% | 0.04% | +16.7% |
| Q3 2021 | $1,971,000 | -11.6% | 24,501 | -11.5% | 0.03% | -9.1% |
| Q2 2021 | $2,229,000 | +4.5% | 27,688 | +9.6% | 0.03% | 0.0% |
| Q1 2021 | $2,132,000 | -4.4% | 25,274 | -9.1% | 0.03% | -10.8% |
| Q4 2020 | $2,230,000 | -25.4% | 27,789 | -25.2% | 0.04% | -32.7% |
| Q3 2020 | $2,988,000 | -15.4% | 37,160 | -9.4% | 0.06% | -20.3% |
| Q2 2020 | $3,533,000 | +8.8% | 41,029 | +2.6% | 0.07% | -10.4% |
| Q1 2020 | $3,247,000 | -11.8% | 39,993 | -9.1% | 0.08% | +18.5% |
| Q4 2019 | $3,681,000 | -4.9% | 44,017 | -0.5% | 0.06% | -8.5% |
| Q3 2019 | $3,870,000 | +21.6% | 44,247 | +13.9% | 0.07% | +24.6% |
| Q2 2019 | $3,182,000 | +6.9% | 38,853 | +6.1% | 0.06% | +7.5% |
| Q1 2019 | $2,977,000 | +55.6% | 36,611 | +26.0% | 0.05% | +35.9% |
| Q4 2018 | $1,913,000 | +7.7% | 29,060 | +26.1% | 0.04% | +34.5% |
| Q3 2018 | $1,776,000 | +52.7% | 23,038 | +46.3% | 0.03% | +45.0% |
| Q2 2018 | $1,163,000 | +57.0% | 15,750 | +44.2% | 0.02% | +66.7% |
| Q1 2018 | $741,000 | +11.3% | 10,926 | +6.0% | 0.01% | +9.1% |
| Q4 2017 | $666,000 | -8.1% | 10,304 | -10.8% | 0.01% | -8.3% |
| Q3 2017 | $725,000 | +69.8% | 11,558 | +64.1% | 0.01% | +71.4% |
| Q2 2017 | $427,000 | -34.2% | 7,045 | -43.7% | 0.01% | -36.4% |
| Q1 2017 | $649,000 | -16.8% | 12,523 | -28.8% | 0.01% | -15.4% |
| Q4 2016 | $780,000 | -43.9% | 17,594 | -39.8% | 0.01% | -43.5% |
| Q3 2016 | $1,391,000 | -74.7% | 29,220 | -76.0% | 0.02% | -74.2% |
| Q2 2016 | $5,505,000 | -45.7% | 121,748 | -50.7% | 0.09% | -47.3% |
| Q1 2016 | $10,144,000 | -26.0% | 246,940 | -31.3% | 0.17% | -22.5% |
| Q4 2015 | $13,712,000 | +6.0% | 359,429 | -8.7% | 0.22% | +5.8% |
| Q3 2015 | $12,933,000 | -51.9% | 393,687 | +2.3% | 0.21% | -44.2% |
| Q2 2015 | $26,912,000 | +42.5% | 384,843 | +39.5% | 0.37% | +46.4% |
| Q1 2015 | $18,892,000 | +59.1% | 275,794 | +70.2% | 0.25% | +58.5% |
| Q4 2014 | $11,873,000 | +58.9% | 161,999 | +55.6% | 0.16% | +54.4% |
| Q3 2014 | $7,474,000 | -4.8% | 104,132 | -4.1% | 0.10% | -5.5% |
| Q2 2014 | $7,851,000 | +17.0% | 108,594 | +19.1% | 0.11% | +6.9% |
| Q1 2014 | $6,708,000 | +28.2% | 91,170 | +21.2% | 0.10% | +21.4% |
| Q4 2013 | $5,233,000 | +22.3% | 75,246 | +15.5% | 0.08% | +10.5% |
| Q3 2013 | $4,280,000 | +28.3% | 65,154 | +35.2% | 0.08% | +20.6% |
| Q2 2013 | $3,337,000 | – | 48,180 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |